Study of EGF816 in combination with Nivolumab in adult patients with EGFR mutated non-small cell lung cancer and of INC280 in combination with Nivolumab in adult patients with cMet positive non-small ...

Update l'année dernière
Reference: EUCTR2014-003731-20

Study of EGF816 in combination with Nivolumab in adult patients with EGFR mutated non-small cell lung cancer and of INC280 in combination with Nivolumab in adult patients with cMet positive non-small cell lung cancer

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To estimate the clinical activity of Nivolumab in combination with EGF816 or INC280


Inclusion criteria

  • EGFR mutated non-small cell lung cancer and EGFR wild-type non-small cell lung cancer